Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Ekso Bionics Holdings Inc. logo

Ekso Bionics Holdings Inc.

Sector: Healthcare   

Industry: Medical Instruments & Supplies

1.97
 
USD
  
0.03
  
(1.55%)
Optionable: Yes  Market Cap: 27 M  90-day average vol: 175,279

Previous close: 1.94  Open: 1.95  Bid: 1.89  Ask: 2.23
52 week range    
0.62   
   3.13
Peers   
ATRC / 
OSUR / 
STAA / 
Last updated: Wednesday 28th February 2024
49
MarketXLS Rank
60
Value
53
Technical
36
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ATRC

3 B69.864.62

BIOL

0 B-4.40.3943

OSUR

1 B-599.22

STAA

4 B158.173.84
Financials

EKSO Income Statement

Annual
Mar-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends-5 M-10 M
Amortization of intangibles-26000.0-558000.0-535000.0-491000.05 M
Basic EPS from continuing operations-6.45-3.6-28.05-2.21-0.8-1.16
Basic EPS total-6.45-3.6-28.05-12.3-6.6-2.55-2.21-0.8-1.16
Basic weighted shares outstanding5 M7 M1 M2 M4 M5 M7 M12 M13 M
Cost of sales4 M7 M11 M-5 M-7 M-7 M4 M4 M7 M
Depreciation-745000.0-933000.0-2 M-1 M-1 M-690000.0620000.0561000.0486000.0
DepreciationAndAmortization-745000.0-933000.0-2 M-1 M-1 M-690000.0620000.0561000.0486000.0
Diluted EPS total-6.45-3.9-30.75-12.3-6.6-2.55-2.21-0.88-1.16
Diluted normalized net income/share-6.45-3.9-30.75-2.21-0.88-1.16
Diluted weighted shares outstanding5 M7 M1 M2 M4 M5 M7 M12 M13 M
Earnings from equity interest-66000.0
EarningsFromEquityInterestNetOfTax-66000.0
GainOnSaleOfBusiness4 M
GainOnSaleOfSecurity196000.0
GeneralAndAdministrativeExpense7 M7 M11 M11 M12 M7 M8 M11 M11 M
Gross operating profit2 M1 M3 M2 M4 M7 M5 M7 M6 M
ImpairmentOfCapitalAssets189000.0
Income before tax-12292.0-34 M-20 M-23 M-29 M-27 M-12 M-16 M-10 M-15 M
Income restructuring and M&A34 M20 M0.0659000.0-82000.0-49000.0244000.0
Income taxes0.0
Interest income6000.011000.012000.03 M1 M5 M
InterestExpenseNonOperating435000.013000.016000.0648000.0600000.0384000.0139000.0113000.0156000.0
InterestExpenseOperating-441000.0-278000.0
InterestIncomeOperating4 M
MiscOtherSpecialCharges-17 M2 M-166000.08 M11 M14 M-2 M5 M1 M
Net income from total operations-12292.0-34 M-20 M-23 M-29 M-27 M-12 M-16 M-10 M-15 M
NetIncomeCommonStockholders-12292.0-34 M-15 M-13 M-29 M-27 M-12 M-16 M-10 M-15 M
NetIncomeContinuousOperations-12292.0-34 M-20 M-23 M-29 M-27 M-12 M-16 M-10 M-15 M
NetNonOperatingInterestIncomeExpense-429000.0-2000.0-4000.02 M463000.05 M-139000.0-113000.0-156000.0
NonRecurringOperationExpense10941.0
Normalized income-8 M-12 M
Operating income-1351.0-17 M-22 M-28 M-38 M-38 M-31 M-13 M-14 M-16 M
Operating income before depreciation (EBITDA)-12292.0-32 M-19 M-22 M-27 M-25 M-11 M-15 M-9 M-14 M
OperatingExpense-12292.018 M23 M31 M-34 M-31 M-23 M18 M21 M22 M
Other income net17 M-2 M-4 M-8 M-11 M-14 M2 M-5 M-1 M
OtherGandA7 M7 M11 M11 M12 M7 M8 M11 M11 M
OtherOperatingExpenses-146000.0-332000.0-35000.0-55000.0-7000.0-22000.0-48000.0
OtherunderPreferredStockDividend-5 M-10 M
PreferredStockDividends-5 M-10 M
PromotionAndAdvertising-1000.0-25000.0-108000.0-160000.0-123000.0-14000.0
RentAndLandingFees-343000.0-342000.0-400000.011 M12 M7 M
Research & development expense4 M6 M9 M9 M6 M5 M2 M3 M4 M
ResearchExpense4 M6 M9 M9 M6 M5 M2 M3 M4 M
RestructringAndMnAIncome34 M20 M0.0659000.0-82000.0-49000.0244000.0
Revenue per share-1 M-558000.0-535000.0-32000.0-19000.05 M
SalariesAndWages-2 M0.0-2 M-3 M-2 M-50000.0
Selling Gen & administrative expense1351.014 M16 M22 M24 M25 M19 M15 M18 M18 M
SellingAndMarketingExpense1351.07 M9 M11 M13 M14 M11 M8 M7 M7 M
SellingExpense1351.013 M14 M11 M
Special income/charges-10941.0-34 M-20 M-659000.082000.049000.0-433000.0
Total Income available for interest expense (EBIT)-12292.0-33 M-20 M-23 M-28 M-27 M-12 M-16 M-10 M-15 M
Total common shares outstanding6 M970169.01 M1 M4 M4 M6 M13 M13 M13 M
Total net income-12292.0-34 M-20 M-23 M-29 M-27 M-12 M-16 M-10 M-15 M
Total ordinary shares14 M14 M14 M14 M14 M14 M14 M14 M14 M14 M
Total revenues5 M9 M14 M7 M11 M14 M9 M11 M13 M
TotalExpenses-12292.022 M30 M42 M-39 M-38 M-31 M22 M25 M28 M
TotalRevenue5 M9 M14 M7 M11 M14 M9 M11 M13 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University